Literature DB >> 7376395

Significant antigenic drift within the influenza equi 2 subtype in Sweden.

B Klingeborn, G Rockborn, Z Dinter.   

Abstract

Mesh:

Substances:

Year:  1980        PMID: 7376395     DOI: 10.1136/vr.106.16.363

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


× No keyword cloud information.
  5 in total

1.  The acute phase protein serum amyloid A (SAA) as an inflammatory marker in equine influenza virus infection.

Authors:  C Hultén; B Sandgren; E Skiöldebrand; B Klingeborn; G Marhaug; M Forsberg
Journal:  Acta Vet Scand       Date:  1999       Impact factor: 1.695

2.  Development and evaluation of one-step TaqMan real-time reverse transcription-PCR assays targeting nucleoprotein, matrix, and hemagglutinin genes of equine influenza virus.

Authors:  Zhengchun Lu; Thomas M Chambers; Saikat Boliar; Adam J Branscum; Tracy L Sturgill; Peter J Timoney; Stephanie E Reedy; Lynn R Tudor; Edward J Dubovi; Mary Lynne Vickers; Stephen Sells; Udeni B R Balasuriya
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

3.  Analysis of antigenic variation in equine 2 influenza A viruses.

Authors:  V S Hinshaw; C W Naeve; R G Webster; A Douglas; J J Skehel; J Bryans
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

4.  Evidence for the contribution of the host species to the extent of antigenic variation of N1 influenza virus neuraminidase.

Authors:  F Maywald; F X Bosch; M Orlich; R Rott
Journal:  Med Microbiol Immunol       Date:  1983       Impact factor: 3.402

5.  Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8).

Authors:  J Mumford; J M Wood; A M Scott; C Folkers; G C Schild
Journal:  J Hyg (Lond)       Date:  1983-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.